Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Bristol-Myers Squibb Company

Market Cap 110B 96.15B 89.05B 83.36B 156B 10,405B 157B 1,056B 409B 5,121B 414B 405B 17,783B P/E 2026 *
10.6x
P/E 2027 * 10.5x
Enterprise Value 139B 121B 112B 105B 197B 13,100B 198B 1,330B 515B 6,448B 521B 510B 22,389B EV / Sales 2026 *
2.93x
EV / Sales 2027 * 2.86x
Free-Float
69.8%
Yield 2026 *
4.66%
Yield 2027 * 4.79%
1 week-1.30%
Current month-5.42%
1 month-1.87%
3 months+5.99%
6 months+7.53%
Current year+4.42%
1 week 56.24
Extreme 56.24
56.98
1 month 54.95
Extreme 54.95
59.46
Current year 52.02
Extreme 52.02
59.46
1 year 43.5
Extreme 43.5
59.46
3 years 40.1
Extreme 40.1
72.7
5 years 40.1
Extreme 40.1
72.7
10 years 40.1
Extreme 40.1
72.7
Manager TitleAgeSince
Chief Executive Officer 55 2023-10-31
Director of Finance/CFO 58 2019-11-19
Chief Tech/Sci/R&D Officer 53 2021-12-31
Director TitleAgeSince
Chairman 55 2024-03-31
Director/Board Member 61 2016-03-31
Director/Board Member 71 2017-02-20
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.30% - - 110B
-1.21%-3.04%+39.94%+145.38% 980B
-2.48%-5.18%+51.52%+39.07% 550B
-2.14%-4.94%+16.71%+56.15% 382B
+0.25%-3.09%+23.00%+15.81% 316B
+0.61%-1.69%+25.42%+13.64% 272B
+0.22%-3.10%+24.25%+30.21% 268B
+4.59%+1.98%-40.02%-45.89% 199B
-1.19%-4.95%+16.56%+47.00% 182B
-1.35%-1.46%+14.59%+56.94% 154B
Average -0.27%-3.02%+19.11%+39.81% 366.93B
Weighted average by Cap. -0.75%-3.68%+27.80%+63.70%

Financials

2026 *2027 *
Net sales 47.31B 41.25B 38.2B 35.76B 67.07B 4,464B 67.48B 453B 176B 2,197B 178B 174B 7,630B 46.22B 40.3B 37.33B 34.94B 65.53B 4,361B 65.93B 443B 172B 2,147B 174B 170B 7,454B
Net income 10.55B 9.2B 8.52B 7.98B 14.96B 996B 15.05B 101B 39.19B 490B 39.62B 38.77B 1,702B 10.26B 8.95B 8.29B 7.76B 14.55B 968B 14.63B 98.29B 38.09B 477B 38.51B 37.69B 1,655B
Net Debt 28.56B 24.9B 23.06B 21.59B 40.49B 2,695B 40.74B 274B 106B 1,327B 107B 105B 4,606B 22.03B 19.21B 17.79B 16.66B 31.24B 2,079B 31.43B 211B 81.81B 1,023B 82.71B 80.94B 3,553B
Logo Bristol-Myers Squibb Company
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 69.1% of net sales.
Employees
32,500
Date Price Change
26-06-19 56.24 $ 0.00%
26-06-18 56.24 $ 0.00%
26-06-17 56.24 $ 0.00%
26-06-16 56.24 $ -1.30%
26-06-15 56.98 $ 0.00%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
54.00USD
Average target price
63.08USD
Spread / Average Target
+16.81%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!